Aquipta (atozepant) Shows Promise in Preventive Treatment of Episodic Migraines: Phase 3 ELEVATE Study Results

The post Aquipta (atozepant) Shows Promise in Preventive Treatment of Episodic Migraines: Phase 3 ELEVATE Study Results appeared first on News Directory 3.
AbbVie Korea announced on February 13 the full results of the Phase 3 ELEVATE study, which evaluated “Aquipta (ingredient name: atozepant)” in the preventive treatment of episodic headache in patients who did not respond to 2-4 types of oral preventive treatment. on the 23rd which was published in Lancet Neurology. According to the study results, […]